Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-06

Clinical Trial Update: Short Course Glucocorticoid Treatment for PTSD [Phase 4]

View source ↗

Summary

Phase 4 trial update on short course glucocorticoid treatment for post-traumatic stress disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glucocorticoid (glucocorticoid)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Post-traumatic Stress Disorder | Phase 4 | Status: COMPLETED | Results posted: 2020-05-06